Biography

Olga Löblová has a PhD in public policy from Central European University (2016) and MA degrees from the College of Europe (2010) and Sciences Po Paris (2009). Before joining the University of Tübingen, she has worked as a postdoctoral researcher at the University of Cambridge, Department of Sociology, for six years, where she held a Wellcome Trust Fellowship in the Humanities and Social Sciences and the Borysiewicz Biomedical Sciences Fellowship. Olga has taught at Cambridge University, Central European University, Sciences Po Paris, collège universitaire de Dijon, and at College of Europe, Bruges. She also has past experience as a consultant in European and global health policy, and in Brussels pharmaceutical lobbying.

Research Interests

Olga's research focuses on the political economy of resource allocation in health care and the role of experts and evidence in health policy-making. She studies how the varying institutional contexts, diverse configurations of actors’ interests and expertise, as well as different forms of evidence, determine which health technologies and interventions are publicly funded in today’s health systems. Specifically, she researches the politics of health technology assessment (HTA) in health care reimbursement decisions. In the past, she’s also studied the regulation of molecular diagnostics and governance of cancer screening, as well as COVID-19 decision-making. 

She is currently studying pharmaceutical policy as part of her Wellcome Trust grant "Alternative access schemes for pharmaceuticals: bypassing scrutiny?".